Bipolar Research Today is a free monthly online journal that collates and summarizes the latest research about Bipolar, including details on bipolar disorder, symptoms, treatment, depression, medication.
|
|
Volume 3 (2006), Issue 4 (April)
- Reduced Glucocorticoid Receptor alpha Expression in Mood Disorder Patients and First-Degree Relatives.
Biol Psychiatry, 59(8): 689-95. [Abstract] [Full-text]
- A point mutation at the calreticulin gene core promoter conserved sequence in a case of schizophrenia.
Am J Med Genet B Neuropsychiatr Genet, 141(3): 294-5. [Abstract] [Full-text]
- Association of mitochondrial complex I subunit gene NDUFV2 at 18p11 with schizophrenia in the Japanese population.
Am J Med Genet B Neuropsychiatr Genet, 141(3): 301-4. [Abstract] [Full-text]
- Suggestive evidence for association of the circadian genes PERIOD3 and ARNTL with bipolar disorder.
Am J Med Genet B Neuropsychiatr Genet, 141(3): 234-41. [Abstract] [Full-text]
- Neuropsychological dysfunction, soft neurological signs and social disability in euthymic patients with bipolar disorder.
Br J Psychiatry, 188: 366-73. [Abstract] [Full-text]
- What can we conclude from studies on psychotherapy in bipolar disorder? Invited commentary on...Cognitive-behavioural therapy for severe and recurrent bipolar disorders.
Br J Psychiatry, 188: 321-2. [Abstract] [Full-text]
- Cognitive-behavioural therapy for severe and recurrent bipolar disorders: randomised controlled trial.
Br J Psychiatry, 188: 313-20. [Abstract] [Full-text]
- Variation at the DAOA/G30 locus influences susceptibility to major mood episodes but not psychosis in schizophrenia and bipolar disorder.
Arch Gen Psychiatry, 63(4): 366-73. [Abstract] [Full-text]
- Validity of the Distinction Between Primary and Secondary Substance Use Disorder in Patients with Bipolar Disorder: Data from the First 1000 STEP-BD Participants.
Am J Addict, 15(2): 138-43. [Abstract] [Full-text]
- Atypical antipsychotic-induced akathisia with depression: therapeutic role of mirtazapine.
Ann Pharmacother, 40(4): 771-4. [Abstract] [Full-text]
- Translating research into clinical practice: critical interpretation of clinical trials in schizophrenia.
Int Clin Psychopharmacol, 21: S1-S10. [Abstract] [Full-text]
- A prospective high-risk study of the association among maternal negativity, apparent frontal lobe dysfunction, and the development of bipolar disorder.
Dev Psychopathol, 18(2): 573-89. [Abstract] [Full-text]
- Impaired cognition and decision-making in bipolar depression but no 'affective bias' evident.
Psychol Med, 36(5): 629-39. [Abstract] [Full-text]
- A prospective study of the transition rates of subthreshold (hypo)mania and depression in the general population.
Psychol Med, 36(5): 619-27. [Abstract] [Full-text]
- Structural brain correlates of IQ changes in bipolar disorder.
Psychol Med, 36(5): 609-18. [Abstract] [Full-text]
- In this issue.
Psychol Med, 36(5): 573-4. [Abstract] [Full-text]
- The extracellular signal-regulated kinase pathway: an emerging promising target for mood stabilizers.
Curr Opin Psychiatry, 19(3): 313-23. [Abstract] [Full-text]
- Cannabidiol, a Cannabis sativa constituent, as an antipsychotic drug.
Braz J Med Biol Res, 39(4): 421-9. [Abstract] [Full-text]
- Safety and tolerability of mood-stabilising anticonvulsants in the elderly.
Expert Opin Drug Saf, 5(3): 401-16. [Abstract] [Full-text]
- Neurocognition as a stable endophenotype in bipolar disorder and schizophrenia.
J Nerv Ment Dis, 194(4): 255-60. [Abstract] [Full-text]
- Comorbid medical and psychiatric conditions and substance abuse in HCV infected persons on dialysis.
J Hepatol, 44(5): 864-8. [Abstract] [Full-text]
- Is Competition between Li(+) and Mg(2+) the Underlying Theme in the Proposed Mechanisms for the Pharmacological Action of Lithium Salts in Bipolar Disorder?
Acc Chem Res, 39(4): 283-91. [Abstract] [Full-text]
- Cognitive compromise in bipolar disorder with chronic cannabis use: cause or consequence?
Expert Rev Neurother, 6(4): 591-8. [Abstract] [Full-text]
- Biosynthesis of dermatan sulfate: chondroitin-glucuronate C5-epimerase is identical to SART2.
J Biol Chem, 281(17): 11560-8. [Abstract] [Full-text]
- Cognitive functioning in bipolar patients receiving lamotrigine: preliminary results.
J Clin Psychopharmacol, 26(2): 178-81. [Abstract] [Full-text]
- Social anxiety disorder comorbidity in patients with bipolar disorder: A clinical replication.
J Anxiety Disord. [Abstract] [Full-text]
- Neural stem cell proliferation is decreased in schizophrenia, but not in depression.
Mol Psychiatry, 11(5): 514-22. [Abstract] [Full-text]
- Serum brain-derived neurotrophic factor is decreased in bipolar disorder during depressive and manic episodes.
Neurosci Lett, 398(3): 215-9. [Abstract] [Full-text]
- XBP1 induces WFS1 through an endoplasmic reticulum stress response element-like motif in SH-SY5Y cells.
J Neurochem, 97(2): 545-55. [Abstract] [Full-text]
- Use of phenotypic covariates in association analysis by sequential addition of cases.
Eur J Hum Genet, 14(5): 529-34. [Abstract] [Full-text]
- Clinical outcome in patients with bipolar I disorder, obsessive compulsive disorder or both.
Hum Psychopharmacol, 21(3): 189-93. [Abstract] [Full-text]
- Comparisons of perceived quality of life across clinical states in bipolar disorder: data from the first 2000 Systematic Treatment Enhancement Program for Bipolar Disorder (STEP-BD) participants.
Compr Psychiatry, 47(3): 161-8. [Abstract] [Full-text]
- The role of quetiapine in the treatment of bipolar disorder.
Expert Opin Pharmacother, 7(7): 929-40. [Abstract] [Full-text]
- Lack of pharmacokinetic interaction between lamotrigine and olanzapine in healthy volunteers.
Pharmacotherapy, 26(5): 627-33. [Abstract] [Full-text]
- Lamotrigine-associated anticonvulsant hypersensitivity syndrome in bipolar disorder.
Prog Neuropsychopharmacol Biol Psychiatry, 30(4): 741-4. [Abstract] [Full-text]
© 2004-2008 Bipolar Research Today. All Rights Reserved.
|
|